US 12173089
Inhibition of pulmonary fibrosis with nutlin-3A and peptides
granted A61KA61K31/497A61K38/00
Quick answer
US patent 12173089 (Inhibition of pulmonary fibrosis with nutlin-3A and peptides) held by The Board of Regents of the University of Texas System expires Mon Dec 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Dec 24 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K31/497, A61K38/00, A61K38/08, A61K38/177